Chemical Structure : EGF816 mesylate
CAS No.: 1508250-72-3
Catalog No.: PC-43274Not For Human Use, Lab Use Only.
EGF816 (Nazartinib) is a potent, irreversible, mutant-selective EGFR inhibitor with Ki and Kinact of 31 nM and 0.222 min-1, respectively.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $105 | In stock | |
25 mg | $315 | In stock | |
100 mg | $985 | In stock | |
500 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
EGF816 (Nazartinib) is a potent, irreversible, mutant-selective EGFR inhibitor with Ki and Kinact of 31 nM and 0.222 min-1, respectively; shows potent inhibition of pEGFR levels in H3255, HCC827, and H1975 with EC50 of 5, 1, and 3 nM, which harbor the L858R, Ex19del, and L858R/T790M mutations, respectively, inhibitscell proliferation with EC50 of 9, 11, and 25 nM, but not the WT EGFR-containing patient-derived cell lines; potently inhibits the most common EGFR mutations L858R, Ex19del, and T790M in vitro; causes tumor regressions in vivo in several patient-derived xenograft models, also demonstrates antitumor activity in exon 20 insertion mutant model.
Lung Cancer
Phase 3 Clinical
M.Wt | 591.122 | |
Formula | C27H35ClN6O5S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
4-Pyridinecarboxamide, N-[7-chloro-1-[(3R)-1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]hexahydro-1H-azepin-3-yl]-1H-benzimidazol-2-yl]-2-methyl-, methanesulfonate (1:1) |
1. Lelais G, et al. J Med Chem. 2016 Jul 28;59(14):6671-89.
2. Jia Y, et al. Cancer Res. 2016 Mar 15;76(6):1591-602.
3. Liao BC, et al. Lung Cancer. 2017 Aug;110:7-13.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright